Internal Medicine

3151 questions

Question 961Question →

A primary care physician is evaluating several patients in an outpatient clinic. Match each patient's clinical presentation with the most appropriate initial management step.

Click a left item, then click its matching right item

Items

A 45-year-old man with a BMI of 34 kg/m², asymptomatic, with two separate fasting plasma glucose readings of 135 mg/dL and a hemoglobin A1c of 7.2%.
A 32-year-old woman with a 6-month history of intermittent lower abdominal cramping relieved by defecation, alternating diarrhea and constipation, and unremarkable basic laboratory tests.
A 60-year-old man with newly diagnosed essential hypertension (blood pressure consistently 145/90 mmHg) and no other medical comorbidities.
A 50-year-old woman presenting with progressive fatigue, unexpected weight gain, cold intolerance, a markedly elevated TSH, and low free T4.

Matches

Show answer & explanation

Answer

Match the diabetes presentation with metformin, IBS with low-FODMAP diet, essential hypertension with primary antihypertensives, and hypothyroidism with levothyroxine.
Each clinical vignette provides a classic, straightforward presentation of a very common primary care condition. The first-line management for type 2 diabetes is metformin; for IBS is dietary modification; for uncomplicated hypertension is a thiazide, CCB, or ACE inhibitor; and for primary hypothyroidism is levothyroxine.

Step-by-Step Solution

1
Analyze the first clinical vignette.
Identify a diagnosis of type 2 diabetes mellitus in a patient without contraindications to metformin.
Establishing the diagnosis dictates the standard first-line therapy (metformin and lifestyle changes).
2
Analyze the second clinical vignette.
Identify a diagnosis of irritable bowel syndrome (IBS) based on the Rome criteria (pain relieved by defecation, altered bowel habits).
Recognizing IBS allows for appropriate conservative and symptom-based management rather than invasive testing.
3
Analyze the third clinical vignette.
Identify uncomplicated essential hypertension.
Guidelines recommend starting with a thiazide, calcium channel blocker, or ACE inhibitor for uncomplicated hypertension.
4
Analyze the fourth clinical vignette.
Identify overt primary hypothyroidism (elevated TSH, low free T4).
The standard of care for primary hypothyroidism is levothyroxine replacement.

Key Concept

First-line outpatient management of common internal medicine conditions (Type 2 Diabetes Mellitus, IBS, Essential Hypertension, Primary Hypothyroidism).
Estimated Time:1m 0s
Question 962Question →

A 6464-year-old man comes to the office complaining of a progressive, dry cough and worsening shortness of breath upon exertion for the past 44 months. He has a 1212-year history of seropositive rheumatoid arthritis, currently treated with weekly methotrexate and daily folic acid. He also takes over-the-counter ibuprofen for occasional joint pain. He has a 2525-pack-year smoking history but quit 55 years ago. Vital signs show a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure of 128/82 mm Hg128/82\text{ mm Hg}, pulse of 84/min84\text{/min}, and respiratory rate of 18/min18\text{/min}. Pulse oximetry is 94%94\% on ambient air. Physical examination shows bilateral ulnar deviation and metacarpophalangeal joint subluxation. Lung auscultation reveals fine, end-inspiratory crackles prominently at both lung bases. There is no wheezing. Cardiovascular examination shows a regular rate and rhythm with no murmurs, gallops, or jugular venous distention. There is no lower extremity edema. Laboratory studies reveal an erythrocyte sedimentation rate of 45 mm/h45\text{ mm/h} and a normal complete blood count. A plain chest radiograph obtained in the clinic shows bilateral, fine reticular opacities at the lung bases.

Which of the following is the most appropriate next step in the management of this patient's respiratory symptoms?

Show answer & explanation

Answer: High-resolution computed tomography of the chest

Answer

High-resolution computed tomography of the chest
The correct answer is high-resolution computed tomography of the chest. This patient's progressive exertional dyspnea, dry cough, fine end-inspiratory crackles, and reticular opacities on chest radiography are highly characteristic of interstitial lung disease (ILD). Patients with rheumatoid arthritis are at significant risk for developing ILD as a direct extra-articular manifestation of the disease itself, or as a rare but severe pulmonary toxicity from disease-modifying antirheumatic drugs (DMARDs) such as methotrexate. Because plain chest radiography lacks the sensitivity and specificity to adequately evaluate the lung parenchyma, high-resolution computed tomography (HRCT) of the chest is the diagnostic modality of choice to confirm the presence of ILD, characterize its specific radiologic pattern (e.g., usual interstitial pneumonia), and determine the extent of lung involvement.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and medical history.
The patient has progressive dyspnea, a dry cough, and basilar crackles, in the setting of long-standing rheumatoid arthritis and methotrexate use.
To identify the most likely underlying pathophysiological process driving the symptoms.
2
Interpret the physical exam and initial imaging findings.
Fine end-inspiratory crackles and reticular opacities on chest radiography strongly suggest interstitial lung disease (ILD). The absence of wheezing, fever, or signs of volume overload rules out COPD, pneumonia, and heart failure.
To narrow the differential diagnosis and exclude common pulmonary or cardiac exacerbations.
3
Determine the optimal diagnostic test for the suspected condition.
High-resolution computed tomography (HRCT) of the chest is selected as the most appropriate next step.
HRCT is the gold standard imaging modality for diagnosing, characterizing, and determining the extent of ILD.

Key Concept

Interstitial lung disease is a serious extra-articular complication of rheumatoid arthritis and a potential adverse effect of methotrexate therapy. High-resolution computed tomography (HRCT) of the chest is the most appropriate next step for definitive diagnosis when clinical and radiographic findings suggest the condition.
Question 963Question →

A 52-year-old man is evaluated in the hospital on day 3 of admission for severe right lower extremity cellulitis and fever. On presentation to the emergency department, his temperature was 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}) and his blood pressure was 92/58 mmHg92/58\text{ mmHg}. Blood cultures were drawn, and he was empirically started on intravenous vancomycin and piperacillin-tazobactam along with fluid resuscitation. Today, his temperature is 37.3∘C37.3^\circ\text{C} (99.1∘F99.1^\circ\text{F}), his blood pressure is 124/78 mmHg124/78\text{ mmHg}, and the erythema and induration of his right leg have significantly decreased. The admission blood cultures are now growing *Staphylococcus aureus* in both sets. Susceptibility testing demonstrates that the organism is resistant to penicillin, but susceptible to oxacillin, cefazolin, and vancomycin. Which of the following is the most appropriate next step in this patient's pharmacotherapy?

Show answer & explanation

Answer: Discontinue current antibiotics and start intravenous cefazolin

Answer

The most appropriate next step is to discontinue the broad-spectrum empiric regimen (vancomycin and piperacillin-tazobactam) and initiate targeted, narrow-spectrum therapy with intravenous cefazolin.
The correct course of action is to de-escalate the patient's empiric antibiotic regimen to a targeted, narrow-spectrum agent. The blood cultures grew methicillin-susceptible Staphylococcus aureus (MSSA), evident from its susceptibility to oxacillin and cefazolin. For MSSA bacteremia, intravenous antistaphylococcal penicillins (e.g., nafcillin, oxacillin) or first-generation cephalosporins (e.g., cefazolin) are the drugs of choice. These beta-lactam antibiotics have been shown to have faster rates of bacterial clearance and lower rates of treatment failure and mortality compared to vancomycin for MSSA infections. Furthermore, discontinuing piperacillin-tazobactam appropriately narrows the spectrum of coverage, removing unnecessary antipseudomonal and anaerobic activity.

Step-by-Step Solution

1
Interpret the clinical presentation and culture results.
The patient has bacteremia secondary to cellulitis, caused by methicillin-susceptible Staphylococcus aureus (MSSA), as indicated by susceptibility to oxacillin and cefazolin.
Accurate identification of the pathogen and its susceptibility profile is required to tailor antibiotic therapy.
2
Apply principles of antimicrobial stewardship for MSSA bacteremia.
Empiric broad-spectrum coverage must be de-escalated to a definitive narrow-spectrum agent.
Targeted therapy minimizes toxicity, reduces the risk of Clostridioides difficile infection, and prevents the development of antimicrobial resistance.
3
Select the optimal agent and route for MSSA bacteremia.
Intravenous beta-lactams like cefazolin or nafcillin/oxacillin are chosen over vancomycin due to superior clinical outcomes.
S. aureus bacteremia carries a high risk of metastatic infection (e.g., endocarditis), requiring aggressive IV therapy with the most bactericidal agent available. Vancomycin has slower bacterial clearance and higher failure rates for MSSA compared to beta-lactams.

Key Concept

Empiric broad-spectrum antibiotics should be de-escalated to targeted, narrow-spectrum intravenous beta-lactams (e.g., cefazolin, nafcillin) for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Question 964Question →

During an urgent clinic visit, a 68-year-old male reports a one-week history of progressively worsening shortness of breath, lightheadedness, and profound fatigue. The patient was diagnosed with extensive-stage small cell lung cancer three months ago and recently completed his second cycle of chemotherapy. His medical history also includes severe chronic obstructive pulmonary disease.

Vital signs reveal a temperature of 37.1°C (98.8°F), pulse of 116/min, respirations of 24/min, and blood pressure of 105/85 mmHg. Oxygen saturation is 93% on room air. Physical examination demonstrates elevated jugular venous pressure. Heart sounds are distant and difficult to auscultate. Lung examination reveals faint scattered wheezes bilaterally. Blood pressure testing reveals a decrease in systolic pressure of 18 mmHg during normal inspiration. Recent laboratory studies are unremarkable, with a normal leukocyte count and a serum sodium level of 132 mEq/L.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Perform a bedside echocardiogram

Answer

The most appropriate next step in management is to perform a bedside echocardiogram.
The correct action is to perform a bedside echocardiogram because the patient is demonstrating classic signs of cardiac tamponade (hypotension, elevated jugular venous pressure, distant heart sounds, and pulsus paradoxus). In patients with lung cancer, malignant involvement of the pericardium is a common cause of pericardial effusions. A bedside echocardiogram provides immediate, non-invasive confirmation of the effusion and signs of tamponade physiology (such as right atrial and ventricular collapse during diastole), allowing for safe and targeted therapeutic pericardiocentesis.

Step-by-Step Solution

1
Identify the key clinical signs indicating an oncologic emergency.
The patient exhibits Beck's triad (hypotension, distended neck veins, and muffled heart sounds) along with pulsus paradoxus (systolic blood pressure drop >10 mmHg during inspiration) and sinus tachycardia.
Recognizing this constellation of signs is critical to differentiating an acute cardiovascular event from an underlying pulmonary or metabolic issue.
2
Determine the underlying pathophysiology causing the hemodynamic instability.
The physical exam findings in a patient with a known thoracic malignancy strongly point to a malignant pericardial effusion leading to cardiac tamponade.
Cardiac tamponade causes obstructive shock, limiting diastolic filling and resulting in reduced cardiac output.
3
Select the best initial diagnostic or management modality.
Echocardiography is the diagnostic test of choice to confirm the presence of fluid and evaluate for right ventricular diastolic collapse before proceeding to therapeutic pericardiocentesis.
Confirming the diagnosis non-invasively and rapidly is necessary to guide life-saving drainage procedures.

Key Concept

Malignant pericardial effusion with cardiac tamponade presents with Beck's triad and pulsus paradoxus, requiring prompt echocardiography for diagnosis.
Estimated Time:1m 0s
Question 965Question →

A 58-year-old female presents to an urgent care facility reporting progressively worsening shortness of breath over the last three days. She notes that she must prop herself up on multiple pillows at night to sleep comfortably. Her medical history includes long-standing type 2 diabetes mellitus, hypertension, and a 20-pack-year smoking history. Vital signs show a blood pressure of 162/94 mmHg, heart rate of 98/min, respiratory rate of 24/min, and oxygen saturation of 92% on ambient air. Physical examination reveals prominent jugular venous pulsations and fine bibasilar crackles on lung auscultation. Trace bilateral pedal edema is also present. Which of the following is the most appropriate initial pharmacological management for this patient's acute symptoms?

Show answer & explanation

Answer: Administration of an intravenous loop diuretic

Answer

Administration of an intravenous loop diuretic
The patient's presentation of progressive dyspnea, orthopnea (sleeping on multiple pillows), jugular venous distension, bibasilar crackles, and pedal edema is highly characteristic of acute decompensated heart failure with volume overload. The most appropriate initial management is the administration of an intravenous loop diuretic. This intervention provides rapid symptomatic relief by promoting diuresis and inducing mild venodilation, thereby reducing cardiac preload and resolving pulmonary congestion.

Step-by-Step Solution

1
Analyze the patient's symptoms and physical exam findings.
The patient has orthopnea, jugular venous distension, bibasilar crackles, and pedal edema.
These are the classic signs of acute decompensated heart failure with volume overload.
2
Determine the most appropriate initial pharmacological intervention.
Intravenous loop diuretics (such as torsemide, bumetanide, or furosemide) should be administered.
Loop diuretics rapidly reduce cardiac preload and pulmonary congestion by promoting diuresis and venodilation, directly addressing the underlying mechanism of the patient's dyspnea.

Key Concept

Diagnosis and acute management of decompensated heart failure
Question 966Question →

A 31-year-old woman visits the ambulatory clinic complaining of severe fatigue, low-grade fevers, and generalized joint achiness that has gradually worsened over the past two months. She recently started a landscaping business and notes that spending hours in the sun causes a bright, flat red rash to appear across her nose and cheeks. On physical examination, her temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}). A confluent, erythematous rash is visible over the malar eminences, notably sparing the nasolabial folds. She has mild synovial thickening and tenderness in the wrists and proximal interphalangeal joints bilaterally. Which of the following laboratory findings is most specific for this patient's likely diagnosis?

Show answer & explanation

Answer: Anti-double-stranded DNA antibodies

Answer

Anti-double-stranded DNA antibodies
The correct answer is Anti-double-stranded DNA antibodies. This patient presents with a classic clinical picture of Systemic Lupus Erythematosus (SLE), characterized by a photosensitive malar rash that classically spares the nasolabial folds, fatigue, low-grade fevers, and non-erosive polyarthritis. In the diagnostic evaluation of suspected SLE, Antinuclear antibodies (ANA) are typically checked first because they are highly sensitive (positive in >95% of patients); however, they lack specificity. To confirm the diagnosis, highly specific autoantibodies such as Anti-double-stranded DNA (anti-dsDNA) or Anti-Smith antibodies are required. Anti-dsDNA is not only highly specific for SLE, but its titers frequently fluctuate with disease activity and correlate strongly with the development of lupus nephritis.

Step-by-Step Solution

1
Identify the patient's core clinical syndrome based on the physical exam and history.
The patient exhibits a malar rash sparing the nasolabial folds, photosensitivity, fatigue, low-grade fevers, and polyarthritis.
These are classic hallmark features of Systemic Lupus Erythematosus (SLE).
2
Determine the diagnostic test characteristics required by the question.
The question specifically asks for the most 'specific' laboratory finding to confirm the diagnosis.
Differentiating between sensitive screening tests and specific confirmatory tests is a crucial step in rheumatologic diagnostic workups.
3
Evaluate the provided autoantibodies for their specificity to SLE.
Anti-double-stranded DNA (anti-dsDNA) antibodies are highly specific for SLE, whereas Antinuclear antibodies (ANA) are highly sensitive but poorly specific.
Selecting the highly specific marker correctly confirms the diagnosis suspected by the clinical presentation.

Key Concept

Diagnosis of Systemic Lupus Erythematosus (SLE) and distinguishing between sensitive screening tests (ANA) and highly specific confirmatory tests (Anti-dsDNA, Anti-Smith).
Question 967Question →

A 72-year-old woman is evaluated in the hospital for progressive lethargy and confusion over the past 24 hours. She was admitted 4 days ago for an acute exacerbation of chronic obstructive pulmonary disease (COPD). On admission, she was started on intravenous methylprednisolone, nebulized ipratropium-albuterol, and empiric piperacillin-tazobactam. She was also continued on her home dose of furosemide for a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 35%. Her other home medications include lisinopril and levothyroxine.

Her temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), blood pressure is 100/60 mm Hg100/60\text{ mm Hg}, pulse is 110/min110\text{/min}, and respirations are 22/min22\text{/min}. Physical examination shows dry mucous membranes. The jugular venous pressure is 4 cm H2O4 \text{ cm H}_2\text{O}. Lung auscultation reveals distant breath sounds with faint expiratory wheezes and fine bibasilar crackles. Cardiac examination shows a regular tachycardia with no murmurs or gallops.

Laboratory studies show:
Sodium: 136 mEq/L136 \text{ mEq/L}
Potassium: 2.8 mEq/L2.8 \text{ mEq/L}
Chloride: 92 mEq/L92 \text{ mEq/L}
Bicarbonate: 36 mEq/L36 \text{ mEq/L}
Blood urea nitrogen: 52 mg/dL52 \text{ mg/dL}
Creatinine: 2.3 mg/dL2.3 \text{ mg/dL} (baseline 1.1 mg/dL1.1 \text{ mg/dL})
Thyroid-stimulating hormone (TSH): 0.1μU/mL0.1 \mu\text{U/mL} (normal: 0.4–4.0μU/mL0.4–4.0 \mu\text{U/mL})
Free T4: 1.0 ng/dL1.0 \text{ ng/dL} (normal: 0.9–1.7 ng/dL0.9–1.7 \text{ ng/dL})

Arterial blood gas on 2 L/min2 \text{ L/min} oxygen by nasal cannula shows:
pH: 7.547.54
PaCO₂: 48 mm Hg48 \text{ mm Hg}
PaO₂: 68 mm Hg68 \text{ mm Hg}

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous 0.9% normal saline and potassium chloride

Answer

Administer intravenous 0.9% normal saline and potassium chloride
The correct answer is to administer intravenous 0.9% normal saline and potassium chloride. This patient presents with lethargy, tachycardia, hypotension, and laboratory evidence of severe hypokalemia, acute kidney injury (BUN to creatinine ratio > 20:1), and a primary metabolic alkalosis (pH 7.54, bicarbonate 36 mEq/L). This presentation is classic for a contraction alkalosis, a chloride-responsive metabolic alkalosis driven by aggressive loop diuretic (furosemide) use leading to severe volume depletion. The volume contraction activates the renin-angiotensin-aldosterone system, which promotes sodium reabsorption at the expense of potassium and hydrogen ion excretion, perpetuating the alkalemia. The elevated PaCO2 of 48 mm Hg represents perfect respiratory compensation (Expected PaCO2 = 40 + [0.7 × 12] = 48.4 mm Hg), definitively ruling out acute respiratory failure. The definitive treatment for chloride-responsive metabolic alkalosis is volume repletion with 0.9% normal saline (which provides chloride to enable renal bicarbonate excretion) and aggressive potassium replacement.

Step-by-Step Solution

1
Analyze the patient's volume status and renal function.
The patient is profoundly volume depleted (hypotension, tachycardia, dry mucous membranes, JVP of 4 cm H2O) with a prerenal acute kidney injury indicated by a BUN/Creatinine ratio greater than 20:1.
Establishing volume status is critical for interpreting metabolic derangements and guiding therapy.
2
Interpret the arterial blood gas and electrolyte panel.
The pH of 7.54 and elevated bicarbonate of 36 mEq/L indicate a primary metabolic alkalosis. Severe hypokalemia (2.8 mEq/L) is concurrently present.
Identifying the primary acid-base disorder dictates the subsequent calculation of expected respiratory compensation.
3
Calculate the expected respiratory compensation for the metabolic alkalosis.
Using the formula: Expected PaCO2 = 40 + [0.7 × (actual HCO3 - 24)], the expected PaCO2 = 40 + [0.7 × (36 - 24)] = 40 + 8.4 = 48.4 mm Hg. The actual PaCO2 of 48 mm Hg demonstrates appropriate compensation.
This rules out a superimposed primary respiratory acidosis (hypercapnia) that might otherwise be suspected in a COPD patient.
4
Determine the therapeutic intervention for the diagnosed pathology.
The diagnosis is chloride-responsive contraction alkalosis secondary to furosemide use. Treatment involves stopping the offending agent and administering isotonic normal saline and potassium chloride.
Saline restores intravascular volume and provides chloride, allowing the kidneys to excrete excess bicarbonate. Potassium repletion corrects the hypokalemia, which otherwise sustains metabolic alkalosis by promoting renal hydrogen ion excretion.

Key Concept

Management of contraction alkalosis (chloride-responsive metabolic alkalosis) in a medically complex patient requires volume expansion with isotonic saline and correction of associated hypokalemia.
Question 968Question →

A 65-year-old woman is hospitalized for a deep vein thrombosis and treated with an unfractionated heparin infusion. On day 66 of hospitalization, her platelet count falls from 240,000/mm3240,000/\text{mm}^3 on admission to 75,000/mm375,000/\text{mm}^3. Physical examination reveals a new, painful, swollen, and pulseless right foot. Her 4T score is calculated to be 77, indicating a high probability of heparin-induced thrombocytopenia (HIT) complicated by arterial thrombosis. Arrange the following management steps in the correct chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue all heparin, immediately initiate a non-heparin anticoagulant like argatroban, wait for platelet count recovery to at least 150,000/mm3150,000/\text{mm}^3, then initiate warfarin, and finally overlap both agents until the INR is therapeutic.
The clinical management of Heparin-Induced Thrombocytopenia (HIT) relies on a rigid chronological sequence. Upon suspecting HIT (e.g., a high 4T score), all heparin must be discontinued to stop the immune trigger. Because patients remain at extremely high risk for thrombosis, an alternative anticoagulant (e.g., argatroban, bivalirudin) must be started immediately. The timing of the transition to oral warfarin is heavily tested: warfarin must NEVER be started until the platelet count has recovered to ≥150,000/mm3\geq 150,000/\text{mm}^3. Starting warfarin earlier causes a rapid decline in Protein C (a natural anticoagulant with a short half-life), worsening the hypercoagulable state and risking venous limb gangrene. Once platelets recover, warfarin is started, and the two anticoagulants must be overlapped until the INR is therapeutic for 4848 hours.

Step-by-Step Solution

1
Recognize high-probability HIT and immediately stop all heparin exposure.
Halts the formation of new PF4-heparin immune complexes.
Continuing heparin fuels the underlying pathophysiology of platelet activation and thrombosis.
2
Start an alternative anticoagulant such as a direct thrombin inhibitor (argatroban).
Provides immediate therapeutic anticoagulation.
HIT is extremely prothrombotic; stopping heparin alone is insufficient to prevent severe thrombotic complications like limb loss.
3
Monitor platelet counts daily until they reach ≥150,000/mm3\geq 150,000/\text{mm}^3.
Identifies the resolution of the acute thrombocytopenic phase.
Transitioning to oral vitamin K antagonists during acute thrombocytopenia is strictly contraindicated.
4
Start oral warfarin therapy only after platelet recovery is confirmed.
Begins long-term oral anticoagulation.
Early warfarin use causes rapid depletion of Protein C, which can lead to catastrophic venous limb gangrene.
5
Continue the direct thrombin inhibitor alongside warfarin for at least 55 days and until the INR is ≥2.0\geq 2.0 for 4848 hours.
Ensures continuous anticoagulant coverage during the transition.
Warfarin creates a transient hypercoagulable state during the first few days of therapy due to differing half-lives of vitamin K-dependent factors.

Key Concept

Management algorithm and therapeutic sequencing for Heparin-Induced Thrombocytopenia (HIT)
Question 969Question →

A 59-year-old woman is evaluated in the hospital on day 3 of admission for acute cholangitis. She initially presented with fever, right upper quadrant pain, and jaundice. She underwent an uncomplicated endoscopic retrograde cholangiopancreatography (ERCP) with stone extraction on the day of admission and was started on empiric piperacillin-tazobactam and vancomycin. She is currently afebrile and her hemodynamics are stable.

Blood cultures drawn on admission are now positive for *Klebsiella aerogenes*. Antimicrobial susceptibility testing is reported as follows:

Antimicrobial AgentResult
AmpicillinResistant
CefazolinResistant
CeftriaxoneSusceptible
CeftazidimeSusceptible
CefepimeSusceptible
Piperacillin-tazobactamSusceptible
MeropenemSusceptible

Which of the following is the most appropriate definitive pharmacotherapy for this patient?

Show answer & explanation

Answer: Cefepime

Answer

Cefepime is the most appropriate definitive therapy for this infection.
Cefepime is the correct answer because it is a fourth-generation cephalosporin that is highly stable against hydrolysis by AmpC beta-lactamases. Current infectious disease guidelines recommend cefepime as the definitive therapy of choice for invasive infections caused by moderate-to-high risk AmpC producers (such as Klebsiella aerogenes, Enterobacter cloacae, and Citrobacter freundii) when the isolate demonstrates in vitro susceptibility. This approach effectively treats the infection while sparing carbapenems.

Step-by-Step Solution

1
Identify the infecting organism and its intrinsic resistance profile.
The organism is Klebsiella aerogenes, which is a known moderate-to-high risk AmpC beta-lactamase producer (SPACE/HECK-YES organisms).
Organism identification dictates the rules for interpreting in vitro susceptibility results, particularly regarding inducible resistance.
2
Evaluate the viability of third-generation cephalosporins based on the organism type.
Ceftriaxone must be avoided despite testing susceptible in vitro.
Exposure to ceftriaxone can induce AmpC gene derepression, leading to rapid in vivo resistance, hydrolysis of the antibiotic, and clinical failure.
3
Select the optimal targeted therapy among the remaining active agents.
Cefepime is selected over meropenem and piperacillin-tazobactam.
Cefepime is stable against AmpC hydrolysis. It is preferred over carbapenems to maintain antimicrobial stewardship, while piperacillin-tazobactam has unacceptably high failure rates for invasive AmpC infections.

Key Concept

Treatment of invasive AmpC-producing Enterobacterales (e.g., Klebsiella aerogenes, Enterobacter cloacae) requires cefepime or a carbapenem; third-generation cephalosporins must be avoided due to the high risk of inducible resistance.
Estimated Time:1m 30s
Question 970Question →

A 24-year-old woman presents to the university health clinic reporting two days of severe burning upon urination and a sensation of needing to urinate frequently. She denies any fever, chills, flank pain, nausea, or vaginal discharge. Her medical history is unremarkable, and she takes no daily medications other than an oral contraceptive pill. Vital signs include a temperature of 37.1°C (98.8°F), blood pressure of 118/76 mmHg, and a heart rate of 78/min. Physical examination reveals mild suprapubic tenderness but no costovertebral angle tenderness. A clean-catch urinalysis is positive for leukocyte esterase and nitrites, with >50 white blood cells per high-power field. A urine culture is pending. Which of the following is the most appropriate empiric pharmacotherapy for this patient?

Show answer & explanation

Answer: Oral nitrofurantoin

Answer

Oral nitrofurantoin
This patient is presenting with acute uncomplicated cystitis, characterized by dysuria, urinary frequency, and suprapubic pain in the absence of systemic symptoms (fever, chills) or upper urinary tract signs (costovertebral angle tenderness). First-line empiric therapy for uncomplicated cystitis includes oral nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), or a single dose of fosfomycin. Nitrofurantoin is an optimal choice because it concentrates highly in the lower urinary tract and maintains a very low prevalence of bacterial resistance among common uropathogens like Escherichia coli.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's presentation.
The patient has dysuria, urinary frequency, suprapubic tenderness, and a positive urinalysis without fever or flank pain, establishing a diagnosis of acute uncomplicated cystitis.
Differentiating uncomplicated cystitis from complicated urinary tract infections or acute pyelonephritis is essential for selecting the appropriate antibiotic class and route.
2
Select the optimal empiric antibiotic therapy according to current stewardship guidelines.
Oral nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin are the preferred first-line agents.
These agents offer narrow, targeted coverage for common uropathogens (like E. coli) while minimizing collateral damage to the normal flora and preserving broad-spectrum antibiotics for severe infections.

Key Concept

Empiric treatment of acute uncomplicated cystitis and principles of antimicrobial stewardship.
Question 971Question →

Evaluate the following clinical scenarios of patients diagnosed with infective endocarditis. Pair each patient profile with the most appropriate definitive antimicrobial regimen based on current treatment guidelines.

Click a left item, then click its matching right item

Items

A 68-year-old man with newly diagnosed colon adenocarcinoma who develops native valve endocarditis. Blood cultures are positive for Streptococcus gallolyticus.
A 55-year-old woman who underwent mechanical mitral valve replacement 45 days ago and now has echocardiogram-confirmed endocarditis. Blood cultures grow methicillin-resistant Staphylococcus epidermidis.
A 72-year-old man with benign prostatic hyperplasia who develops native aortic valve endocarditis. Blood cultures grow Enterococcus faecalis demonstrating high-level resistance to gentamicin.
A 40-year-old sheep farmer with culture-negative endocarditis, hepatomegaly, and significantly elevated phase I IgG titers against Coxiella burnetii.

Matches

Show answer & explanation

Answer

The correct pairings match each specific pathogen and host profile with its guideline-directed antimicrobial therapy: S. gallolyticus is treated with ceftriaxone; early prosthetic valve S. epidermidis requires vancomycin, rifampin, and gentamicin; E. faecalis with high-level aminoglycoside resistance requires ampicillin and ceftriaxone; and Q fever endocarditis is treated with doxycycline and hydroxychloroquine.
Each pairing reflects the guideline-directed medical therapy for specific subtypes of infective endocarditis. Streptococcus gallolyticus, strongly associated with colonic malignancy, is highly susceptible and effectively treated with ceftriaxone monotherapy. Early prosthetic valve endocarditis caused by methicillin-resistant Staphylococcus epidermidis requires a triple regimen of vancomycin, rifampin (vital for biofilm eradication), and gentamicin (for initial synergy). For Enterococcus faecalis with high-level aminoglycoside resistance, the standard synergy with gentamicin is ineffective; therefore, dual beta-lactam therapy using ampicillin and ceftriaxone is utilized to achieve synergistic bactericidal activity via differential penicillin-binding protein saturation. Finally, Coxiella burnetii causes culture-negative endocarditis that requires treatment with doxycycline and hydroxychloroquine; the latter alkalinizes the acidic phagolysosome where the bacteria reside, allowing doxycycline to effectively kill the pathogen.

Step-by-Step Solution

1
Analyze the first patient with Streptococcus gallolyticus native valve endocarditis.
Identified as a highly penicillin-susceptible streptococcus.
Penicillin G or ceftriaxone monotherapy is the standard of care for highly susceptible streptococcal strains causing native valve endocarditis.
2
Evaluate the second patient with early (less than 2 months) prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Identified the need for broad-spectrum anti-staphylococcal therapy with biofilm penetration and synergistic coverage.
The standard regimen for staphylococcal prosthetic valve endocarditis includes vancomycin (for methicillin resistance), rifampin (essential for sterilizing biofilms on prosthetic material), and gentamicin (for early synergy).
3
Assess the third patient with Enterococcus faecalis demonstrating high-level aminoglycoside resistance (HLAR).
Determined that standard ampicillin-gentamicin synergy cannot be utilized.
Ampicillin combined with ceftriaxone provides synergistic bactericidal activity through complementary binding of different penicillin-binding proteins (PBPs), overcoming the limitation imposed by HLAR.
4
Review the fourth patient with Coxiella burnetii (Q fever) culture-negative endocarditis.
Identified an intracellular pathogen requiring specialized combination therapy.
Q fever endocarditis requires prolonged therapy with doxycycline and hydroxychloroquine, as hydroxychloroquine raises the pH of the phagolysosome, rendering doxycycline bactericidal in that environment.

Key Concept

Definitive antimicrobial therapy for infective endocarditis is tailored to the specific pathogen's resistance mechanisms (e.g., HLAR), the presence of prosthetic material requiring biofilm eradication, and whether the organism is intracellular.
Question 972Question →

A 2828-year-old woman is admitted to the hospital for a 22-week history of high, daily spiking fevers up to 39.8∘C39.8^\circ\text{C} (103.6∘F103.6^\circ\text{F}), severe pharyngitis, and polyarthralgia in her wrists and knees. During the fever spikes, she develops a transient, salmon-colored macular rash on her trunk and extremities. Initial laboratory studies on admission showed:

Laboratory TestResultReference Range
Leukocytes18,500/mm318,500/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Hemoglobin11.2 g/dL11.2\text{ g/dL}12.0−15.5 g/dL12.0-15.5\text{ g/dL}
Platelets450,000/mm3450,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
ESR105 mm/h105\text{ mm/h}0−20 mm/h0-20\text{ mm/h}
CRP140 mg/L140\text{ mg/L}<10 mg/L<10\text{ mg/L}
Ferritin5,500 ng/mL5,500\text{ ng/mL}15−150 ng/mL15-150\text{ ng/mL}

She is treated with high-dose nonsteroidal anti-inflammatory drugs. On day 44 of hospitalization, she rapidly becomes lethargic and hypotensive. Physical examination now reveals marked hepatosplenomegaly. Repeat laboratory studies show:

Laboratory TestResultReference Range
Leukocytes2,100/mm32,100/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Hemoglobin8.4 g/dL8.4\text{ g/dL}12.0−15.5 g/dL12.0-15.5\text{ g/dL}
Platelets42,000/mm342,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
AST850 U/L850\text{ U/L}8−40 U/L8-40\text{ U/L}
ALT720 U/L720\text{ U/L}7−56 U/L7-56\text{ U/L}
Fasting triglycerides520 mg/dL520\text{ mg/dL}<150 mg/dL<150\text{ mg/dL}
Fibrinogen85 mg/dL85\text{ mg/dL}200−400 mg/dL200-400\text{ mg/dL}
ESR12 mm/h12\text{ mm/h}0−20 mm/h0-20\text{ mm/h}
CRP165 mg/L165\text{ mg/L}<10 mg/L<10\text{ mg/L}
Ferritin45,000 ng/mL45,000\text{ ng/mL}15−150 ng/mL15-150\text{ ng/mL}

Which of the following is most likely to be found on further evaluation of this patient's current condition?

Show answer & explanation

Answer: Bone marrow demonstrating active engulfment of hematopoietic cells by macrophages

Answer

Bone marrow demonstrating active engulfment of hematopoietic cells by macrophages.
This patient's acute deterioration is due to Macrophage Activation Syndrome (MAS), a severe and potentially fatal form of secondary hemophagocytic lymphohistiocytosis (HLH). Her initial presentation (quotidian fevers, salmon-colored rash, pharyngitis, polyarthritis, extreme hyperferritinemia) is classic for Adult-Onset Still's disease (AOSD). The acute transition characterized by the sudden onset of pancytopenia (from baseline leukocytosis), hepatosplenomegaly, transaminitis, and soaring ferritin levels is the hallmark of MAS. A critical, high-yield diagnostic clue for MAS is the paradoxical drop in the erythrocyte sedimentation rate (ESR) in the setting of a persistently elevated C-reactive protein (CRP). This occurs because widespread macrophage activation leads to hepatic dysfunction and fibrinogen consumption (hypofibrinogenemia); since ESR relies on fibrinogen to facilitate red blood cell rouleaux formation, the ESR plummets. To confirm MAS, a bone marrow biopsy is typically performed, which characteristically reveals hemophagocytosis (macrophages actively engulfing erythrocytes, leukocytes, and platelets).

Step-by-Step Solution

1
Analyze the initial clinical presentation.
Spiking fevers, salmon-colored rash, polyarthralgia, severe hyperferritinemia, and leukocytosis.
These classic findings strongly suggest Adult-Onset Still's disease (AOSD), establishing the baseline inflammatory condition.
2
Evaluate the clinical deterioration and new laboratory findings.
The patient developed pancytopenia, severe transaminitis, hypertriglyceridemia, hypofibrinogenemia, and a massive ferritin spike.
This multi-system organ failure pattern points toward an aggressive systemic inflammatory storm, specifically Macrophage Activation Syndrome (MAS).
3
Interpret the paradoxical drop in Erythrocyte Sedimentation Rate (ESR).
The ESR dropped from 105 mm/h105\text{ mm/h} to 12 mm/h12\text{ mm/h}, while the CRP remained elevated.
ESR depends heavily on circulating fibrinogen. In MAS, macrophages consume fibrinogen, leading to hypofibrinogenemia and an artificially low ESR despite worsening inflammation.
4
Identify the diagnostic hallmark of the complication.
The clinical picture is secondary hemophagocytic lymphohistiocytosis (HLH), diagnosed by demonstrating hemophagocytosis in the bone marrow.
MAS is a life-threatening complication characterized by uncontrolled activation of macrophages, requiring urgent identification and immunosuppression.

Key Concept

Macrophage Activation Syndrome (MAS)
Question 973Question →

A 6464-year-old man is evaluated in the intensive care unit for a persistent fever. He was admitted 88 days ago for a severe exacerbation of chronic obstructive pulmonary disease and required endotracheal intubation on the second day of admission. Four days ago, he developed a new fever, worsening oxygenation, and thick endotracheal secretions. Blood and lower respiratory tract cultures were obtained, and empiric therapy with intravenous piperacillin-tazobactam and vancomycin was initiated. Today, his temperature is 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), blood pressure is 112/68 mm Hg112/68\text{ mm Hg}, pulse is 102/min102/\text{min}, and leukocyte count is 16,500/mm316,500/\text{mm}^3. Blood cultures have remained sterile. The endotracheal aspirate culture grows \textit{Enterobacter cloacae}. Antimicrobial susceptibility testing shows the isolate is susceptible to ceftriaxone, ceftazidime, cefepime, piperacillin-tazobactam, and meropenem, but resistant to ampicillin and cefazolin. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Intravenous cefepime monotherapy

Answer

The most appropriate next step is to initiate targeted therapy with intravenous cefepime monotherapy. Vancomycin should be discontinued, and piperacillin-tazobactam should be switched to cefepime to avoid inducible resistance while adhering to antibiotic stewardship principles.
The patient has ventilator-associated pneumonia caused by \textit{Enterobacter cloacae}. \textit{E. cloacae} is a classic high-risk organism known to possess an inducible chromosomal AmpC beta-lactamase gene (often remembered as part of the SPACE or HECK-Yes mnemonic). The standard of care for serious infections caused by these organisms is a fourth-generation cephalosporin, such as cefepime. Cefepime is highly stable against hydrolysis by AmpC beta-lactamases and effectively treats the infection while avoiding the unnecessary use of carbapenems. Furthermore, since there is no evidence of a Gram-positive infection, empiric vancomycin must be promptly discontinued.

Step-by-Step Solution

1
Identify the primary site of infection and offending pathogen
Hospital-acquired ventilator-associated pneumonia caused by Enterobacter cloacae.
The patient developed a new fever, thick secretions, and respiratory deterioration 4 days after intubation, with the respiratory culture growing heavy E. cloacae.
2
Determine the resistance risk profile of the isolated pathogen
E. cloacae is a high-risk AmpC beta-lactamase producing organism.
SPACE (Serratia, Pseudomonas, Acinetobacter, Citrobacter, Enterobacter) organisms possess inducible chromosomal AmpC beta-lactamase genes.
3
Evaluate the current empiric antibiotic regimen
Vancomycin should be discontinued; piperacillin-tazobactam is suboptimal for definitive therapy.
No MRSA or other Gram-positive pathogens were isolated, rendering vancomycin unnecessary. Piperacillin-tazobactam is not recommended for severe AmpC infections.
4
Select the optimal definitive therapy based on stewardship guidelines
Cefepime is the preferred agent.
Cefepime is stable against AmpC hydrolysis. Ceftriaxone carries a high risk of inducing resistance, and meropenem should be spared unless the isolate is cefepime-resistant.

Key Concept

AmpC Beta-Lactamase Inducible Resistance and Antibiotic Stewardship
Question 974Question →

Match the following characteristic peripheral blood smear descriptions to the most likely underlying hematologic diagnosis.

Click a left item, then click its matching right item

Items

Peripheral blood smear shows small, mature-appearing lymphocytes with scant cytoplasm and numerous 'smudge' cells.
Peripheral blood smear reveals red blood cells with 'bite-like' deformities and Heinz bodies seen on supravital stain.
Peripheral blood smear demonstrates numerous fragmented red blood cells (schistocytes) and profound thrombocytopenia.
Peripheral blood smear displays large, oval-shaped red blood cells (macroovalocytes) and hypersegmented neutrophils.

Matches

Show answer & explanation

Answer

Smudge cells correspond to Chronic lymphocytic leukemia; bite cells and Heinz bodies correspond to Glucose-6-phosphate dehydrogenase deficiency; schistocytes correspond to Thrombotic thrombocytopenic purpura; and hypersegmented neutrophils correspond to Vitamin B12 deficiency.
Correctly matching the morphological descriptions requires applying the underlying pathophysiology to its visual manifestation: fragile cell membranes in leukemia result in smudge cells, oxidative damage in enzyme deficiency forms Heinz bodies and bite cells, mechanical shearing in small vessels generates schistocytes, and delayed DNA replication in nutritional deficiency leads to hypersegmented nuclear structures.

Step-by-Step Solution

1
Evaluate the first description highlighting smudge cells and mature-appearing lymphocytes.
Identify the condition as Chronic lymphocytic leukemia.
Neoplastic cells in this leukemia are structurally fragile and easily disrupted mechanically on a glass slide.
2
Evaluate the second description highlighting bite cells and Heinz bodies.
Identify the condition as Glucose-6-phosphate dehydrogenase deficiency.
The absence of normal oxidative defense mechanisms causes hemoglobin denaturation, leading to typical inclusion bodies that are removed by the spleen.
3
Evaluate the third description highlighting schistocytes and profound thrombocytopenia.
Identify the condition as Thrombotic thrombocytopenic purpura.
Systemic microthrombi cause both mechanical damage to red blood cells (forming schistocytes) and consumption of platelets.
4
Evaluate the fourth description highlighting macroovalocytes and hypersegmented neutrophils.
Identify the condition as Vitamin B12 deficiency.
Disrupted cell division and delayed nuclear maturation across hematopoietic cell lines cause distinctive megaloblastic morphological changes.

Key Concept

Recognizing specific pathognomonic peripheral blood smear findings is highly effective in differentiating among various leukemias, enzymatic defects, microangiopathic processes, and nutritional deficiencies.
Question 975Question →

Match each clinical scenario of severe or life-threatening bleeding to the most appropriate specific pharmacological reversal agent.

Click a left item, then click its matching right item

Items

A 6565-year-old patient with a deep vein thrombosis develops severe hematemesis while receiving an unfractionated heparin infusion.
A 7272-year-old patient with a mechanical aortic valve presents with an acute intracerebral hemorrhage; current INR is 5.85.8.
A 6868-year-old patient taking a direct thrombin inhibitor for atrial fibrillation requires an emergent laparotomy for a perforated viscus.
A 7070-year-old patient taking a direct factor Xa inhibitor for pulmonary embolism prophylaxis presents with a massive retroperitoneal bleed.

Matches

Show answer & explanation

Answer

Unfractionated heparin is reversed by protamine sulfate. Warfarin is reversed by prothrombin complex concentrate. Direct thrombin inhibitors (like dabigatran) are reversed by idarucizumab. Direct factor Xa inhibitors (like rivaroxaban) are reversed by andexanet alfa.
Each distinct class of anticoagulant medication interrupts the coagulation cascade via a unique mechanism, and therefore requires a highly specific antidote to quickly restore hemostasis in the setting of severe or life-threatening hemorrhage.

Step-by-Step Solution

1
Identify the specific anticoagulant medication or medication class used in each clinical scenario.
Scenario 1 involves unfractionated heparin; Scenario 2 involves a vitamin K antagonist (warfarin, implied by the elevated INR); Scenario 3 involves a direct thrombin inhibitor; Scenario 4 involves a direct factor Xa inhibitor.
Accurate identification of the anticoagulant is required to select the targeted reversal agent.
2
Match the identified anticoagulant with its specific pharmacologic reversal agent for severe bleeding.
Heparin pairs with protamine sulfate; warfarin pairs with prothrombin complex concentrate; direct thrombin inhibitors pair with idarucizumab; direct factor Xa inhibitors pair with andexanet alfa.
Each anticoagulant targets a distinct component of the coagulation cascade, necessitating a unique mechanism of reversal.

Key Concept

Pharmacologic Reversal of Anticoagulants
Estimated Time:1m 0s
Question 976Question →

Match each biologic disease-modifying antirheumatic drug (bDMARD) with its specific mechanism of action and the most characteristic clinical caveat or adverse effect associated with its use.

Click a left item, then click its matching right item

Items

Rituximab
Tocilizumab
Abatacept
Anakinra
Secukinumab

Matches

Show answer & explanation

Answer

Rituximab depletes CD20 and risks HBV reactivation; Tocilizumab inhibits IL-6 and risks GI perforation; Abatacept blocks CD80/86 and risks COPD exacerbation; Anakinra inhibits IL-1 and requires daily injections; Secukinumab neutralizes IL-17A and risks IBD exacerbation.
Each biologic DMARD has a distinct mechanism of action and a unique adverse effect profile that dictates pre-treatment screening and patient selection. Rituximab (anti-CD20) risks HBV reactivation. Tocilizumab (anti-IL-6R) is associated with dyslipidemia and GI perforations. Abatacept (CTLA-4-Ig) can exacerbate COPD. Anakinra (IL-1RA) has a short half-life requiring daily dosing. Secukinumab (anti-IL-17A) can precipitate or worsen inflammatory bowel disease.

Step-by-Step Solution

1
Analyze the mechanism and adverse effects of Rituximab.
Rituximab targets CD20 on B cells. A classic and severe complication is hepatitis B reactivation, necessitating prior screening.
Identifying the target and its black-box warnings isolates the correct match.
2
Analyze the mechanism and adverse effects of Tocilizumab.
Tocilizumab targets the IL-6 receptor. It is uniquely associated with dyslipidemia and an increased risk of lower GI perforation, particularly in patients with diverticular disease.
IL-6 blockade has distinct metabolic and tissue-healing effects.
3
Analyze the mechanism and adverse effects of Abatacept.
Abatacept blocks T-cell costimulation via CD80/86. It has a specific warning for use in patients with underlying COPD due to increased respiratory exacerbations.
Costimulation blockade has specific pulmonary caveats.
4
Analyze the mechanism and adverse effects of Anakinra.
Anakinra is an IL-1 receptor antagonist. Its recombinant protein structure gives it a short half-life, requiring daily dosing.
Dosing frequency is a unique clinical caveat among biologics.
5
Analyze the mechanism and adverse effects of Secukinumab.
Secukinumab targets IL-17A. Because IL-17 maintains gut mucosal integrity, its blockade can induce or worsen Crohn disease and ulcerative colitis.
Understanding the physiological role of IL-17 explains its contraindication in IBD.

Key Concept

The mechanisms of action and highly specific adverse effect profiles of biologic disease-modifying antirheumatic drugs (bDMARDs).
Question 977Question →

A 74-year-old man is admitted to the intensive care unit with septic shock secondary to a severe complicated urinary tract infection. He has a history of neurogenic bladder managed with clean intermittent catheterization. On admission, his temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 82/50 mmHg82/50\text{ mmHg}, and heart rate is 118/min118/\text{min}. He receives aggressive fluid resuscitation and is started on empiric intravenous piperacillin-tazobactam and vancomycin. By hospital day 3, his condition has significantly improved; he is afebrile, hemodynamically stable off vasopressors, and transferred to the general medical floor. Blood cultures and a urine culture obtained on admission both yield *Enterococcus faecalis*. Susceptibility testing indicates the organism is sensitive to ampicillin, vancomycin, linezolid, and daptomycin, but intrinsically resistant to cephalosporins. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue the current regimen and begin intravenous ampicillin

Answer

Discontinue the current regimen and begin intravenous ampicillin
Intravenous ampicillin is the drug of choice for susceptible Enterococcus faecalis. The cornerstone of antimicrobial stewardship is de-escalation: once a patient who initially required empiric broad-spectrum antibiotics (for conditions like septic shock) stabilizes and specific susceptibility data returns, the regimen must be narrowed to the most targeted agent available. Ampicillin provides excellent bactericidal activity against susceptible enterococci without the unnecessary broad-spectrum gram-negative, anaerobic, or MRSA coverage provided by the empiric regimen.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and culture data.
The patient has stabilized from septic shock, and cultures have identified Enterococcus faecalis as the sole pathogen.
Clinical stability and pathogen identification mandate transitioning from empiric to definitive targeted therapy.
2
Analyze the susceptibility profile of the isolated pathogen.
The isolate is susceptible to multiple agents, including ampicillin, vancomycin, linezolid, and daptomycin.
To select the most effective agent with the narrowest possible spectrum.
3
Apply antimicrobial stewardship principles to select definitive therapy.
Ampicillin is selected to replace the broad-spectrum piperacillin-tazobactam and vancomycin.
Ampicillin is the gold-standard, targeted therapy for susceptible E. faecalis, minimizing collateral microbiome damage and preventing resistance.

Key Concept

Once a patient stabilizes and culture sensitivities are available, empiric broad-spectrum antibiotics must be de-escalated to the narrowest effective targeted therapy (e.g., ampicillin for susceptible E. faecalis) to practice proper antimicrobial stewardship.
Question 978Question →

A 54-year-old man develops severe pain, redness, and swelling of his right big toe on postoperative day 3 following an uncomplicated laparoscopic cholecystectomy. He cannot bear weight on the affected foot. His temperature is 37.6°C (99.7°F), blood pressure is 135/85 mm Hg, and pulse is 88/min. Examination shows an exquisitely tender, erythematous, and swollen right first metatarsophalangeal joint. Synovial fluid analysis reveals a leukocyte count of 22,000/mm³ and numerous negatively birefringent, needle-shaped crystals. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer oral indomethacin

Answer

Administer oral indomethacin
The correct answer is to administer an NSAID such as oral indomethacin. This patient presents with a classic acute gout flare (podagra), commonly precipitated by the physiological stress of surgery, changes in diet, or fluctuations in fluid status during hospitalization. The diagnosis is definitively established by the presence of negatively birefringent, needle-shaped monosodium urate crystals in the synovial fluid. The primary goal in acute gout management is the rapid reduction of inflammation, which is achieved through the use of NSAIDs, colchicine, or intra-articular/systemic corticosteroids.

Step-by-Step Solution

1
Analyze the clinical presentation and synovial fluid results.
The patient has an acute monoarthritis on postoperative day 3. The synovial fluid analysis demonstrates a moderately elevated leukocyte count with negatively birefringent, needle-shaped crystals.
Identifying the specific crystal characteristics is required to differentiate gout from other forms of acute arthritis, such as pseudogout or septic arthritis.
2
Synthesize the findings to establish a definitive diagnosis.
The clinical picture is diagnostic for an acute gout flare (podagra), which is frequently triggered by the physiological stress of recent surgery or hospitalization.
Establishing the correct etiology of the joint inflammation dictates the appropriate choice of pharmacotherapy.
3
Determine the most appropriate initial treatment for the diagnosed condition.
Nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin, colchicine, or systemic corticosteroids are the appropriate first-line agents for an acute gout flare.
Acute gout requires rapid anti-inflammatory therapy. Urate-lowering medications should generally be avoided in the acute setting if the patient is not already taking them.

Key Concept

The diagnosis and acute management of a gout flare.
Question 979Question →

A 58-year-old female patient visits the outpatient clinic to discuss a two-month history of progressively worsening shortness of breath. Initially, she noticed breathlessness only when climbing stairs, but she now experiences it after walking short distances on level ground. The patient's medical background is notable for limited cutaneous systemic sclerosis, characterized by diffuse calcinosis cutis, severe esophageal dysmotility, and tightening of the skin over her fingers. She also has a history of primary hypothyroidism and severe digital vasospasm triggered by cold exposure.

Her daily medications include amlodipine, omeprazole, levothyroxine, and sildenafil.

Vital signs are as follows:
- Temperature: 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F})
- Blood pressure: 126/78 mm Hg126/78\text{ mm Hg}
- Heart rate: 94/min94/\text{min}
- Respiratory rate: 22/min22/\text{min}
- Pulse oximetry: 94%94\% on room air

Physical examination reveals clear lung fields bilaterally with no crackles or wheezes. Cardiovascular assessment demonstrates a prominent parasternal impulse and a markedly accentuated pulmonic component of the second heart sound. Examination of the lower extremities shows mild bilateral pitting edema.

Recent laboratory and diagnostic results:

TestResultReference Range
TSH7.4 μU/mL7.4\text{ }\mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL}
Free T41.2 ng/dL1.2\text{ ng/dL}0.8−1.8 ng/dL0.8-1.8\text{ ng/dL}
BNP450 pg/mL450\text{ pg/mL}<100 pg/mL<100\text{ pg/mL}

An electrocardiogram reveals right axis deviation and signs of right ventricular hypertrophy. A chest radiograph demonstrates prominent central pulmonary arteries with rapid peripheral tapering and completely clear lung parenchyma. A transthoracic echocardiogram obtained yesterday estimates a right ventricular systolic pressure of 55 mm Hg55\text{ mm Hg} with normal left ventricular ejection fraction.

Which of the following is the most appropriate next step in the evaluation of this patient's current presentation?

Show answer & explanation

Answer: Perform right heart catheterization

Answer

Perform right heart catheterization
The correct next step is to perform right heart catheterization. This patient's history of limited cutaneous systemic sclerosis (CREST syndrome) combined with exertional dyspnea, a parasternal heave, an accentuated P2, and an elevated right ventricular systolic pressure on echocardiography strongly points to pulmonary arterial hypertension (PAH). While transthoracic echocardiography is the appropriate initial screening test (which she has already undergone), right heart catheterization is mandatory to definitively establish the diagnosis of PAH. It accomplishes this by demonstrating a mean pulmonary arterial pressure (mPAP) > 20 mm Hg20\text{ mm Hg} and a pulmonary capillary wedge pressure (PCWP) <= 15 mm Hg15\text{ mm Hg}. Confirming these hemodynamics is strictly required before initiating advanced pulmonary vasodilator therapies such as endothelin receptor antagonists or prostacyclin analogs.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's history and physical exam.
The patient has progressive exertional dyspnea, a parasternal heave, a loud P2, and lower extremity edema with clear lungs, strongly suggesting right-sided heart failure secondary to pulmonary hypertension.
Correlating physical exam findings with the history of limited cutaneous systemic sclerosis points toward Pulmonary Arterial Hypertension (PAH), a classic and leading cause of mortality in this population.
2
Evaluate the diagnostic workup provided in the vignette.
The chest X-ray and ECG support right heart strain. The transthoracic echocardiogram (TTE) confirms an elevated right ventricular systolic pressure (55 mm Hg55\text{ mm Hg}), providing a positive screening result for PAH.
TTE is the initial screening test of choice for suspected pulmonary hypertension, but it cannot definitively diagnose the condition or rule out occult left-sided heart disease.
3
Determine the required intervention to establish a definitive diagnosis before treatment.
Right heart catheterization must be performed.
Right heart catheterization definitively confirms pre-capillary PAH by demonstrating a mean pulmonary arterial pressure (mPAP) > 20 mm Hg20\text{ mm Hg} and a pulmonary capillary wedge pressure (PCWP) <= 15 mm Hg15\text{ mm Hg}. This is mandatory before starting advanced pulmonary vasodilator therapies.

Key Concept

Pulmonary Arterial Hypertension (PAH) is a major complication of systemic sclerosis; while echocardiography is the best initial screening tool, right heart catheterization is required for definitive diagnosis.
Question 980Question →

An otherwise healthy 45-year-old woman receives treatment in the inpatient ward for an acute complicated urinary tract infection with associated bacteremia. At the time of admission two days ago, she presented with fever, chills, and costovertebral angle tenderness, prompting the initiation of empiric intravenous piperacillin-tazobactam. Today, she has been afebrile for the past 24 hours, her flank pain has nearly resolved, and she is tolerating a regular diet. Final culture results from both blood and urine demonstrate growth of *Escherichia coli*. The susceptibility report indicates resistance to ampicillin, but susceptibility to ceftriaxone, trimethoprim-sulfamethoxazole, levofloxacin, and piperacillin-tazobactam. Based on the culture results and the patient's clinical improvement, what is the most appropriate next step in management?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

Transition to oral trimethoprim-sulfamethoxazole
The correct answer is to transition the patient to oral trimethoprim-sulfamethoxazole. The patient is clinically stable, afebrile, and tolerating an oral diet, which meets the criteria for transitioning from intravenous to oral antibiotics. Furthermore, proper antibiotic stewardship dictates de-escalating from broad-spectrum empiric coverage (like piperacillin-tazobactam) to a narrower-spectrum, targeted agent based on culture and susceptibility data. Trimethoprim-sulfamethoxazole has excellent oral bioavailability and the patient's isolate is explicitly susceptible to it.

Step-by-Step Solution

1
Evaluate the patient's clinical status for transition to oral therapy.
The patient is afebrile, improving, and tolerating an oral diet.
Clinical stability and the ability to take medications by mouth are the primary indications for safely switching from intravenous to oral antibiotics.
2
Analyze the culture and susceptibility data to select a targeted antimicrobial agent.
The Escherichia coli isolate is susceptible to several narrower-spectrum agents, including trimethoprim-sulfamethoxazole.
Antimicrobial stewardship guidelines mandate de-escalating from broad-spectrum empiric therapy to the narrowest effective agent once sensitivities are known.
3
Select the most appropriate oral antibiotic for step-down therapy.
Oral trimethoprim-sulfamethoxazole is chosen over intravenous options.
It provides targeted coverage against the susceptible isolate and has excellent oral bioavailability, allowing for safe completion of the treatment course.

Key Concept

Antibiotic stewardship and de-escalation of antimicrobial therapy
PreviousPage 49 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 49 | Examkin